Farr Miller & Washington’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Farr Miller & Washington's NVS Position: Q3 2021 in Review
Farr Miller & Washington sold out of Novartis (NVS) in Q3 2021, closing a stake of 2,439 shares — an estimated $223K sold.
Farr Miller & Washington first reported a position in NVS in Q2 2014 and held it in 24 quarters. The position peaked at $274K in Q2 2016. 1,080 funds tracked by Wall St. Rank hold NVS as of Q3 2021.
- Farr Miller & Washington reported no remaining Novartis position as of Q3 2021 after selling out during the quarter.
- Farr Miller & Washington sold 2,439 Novartis shares in Q3 2021, an estimated $223K.
- Farr Miller & Washington first reported a position in Novartis in Q2 2014 and held it in 24 quarters.
- Farr Miller & Washington's Novartis position peaked at $274K in Q2 2016.
- 1,080 funds tracked by Wall St. Rank held Novartis as of Q3 2021.
Based on Farr Miller & Washington's 13F filing for Q3 2021, filed 15 Nov 2021.